Repligen (RGEN) Cash Flow Statement

Click line-items for a historical chart and %

Cash flows from operating activities:
Net (loss) income	6.65M
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	3.84M
Stock-based compensation expense	3.34M
Changes in assets and liabilities:
Accounts receivable	-3.27M
Royalties receivable	20K
Inventories	-6.46M
Prepaid expenses and other current assets	820K
Accounts payable	-1.92M
Accrued liabilities	-2.39M
Long-term liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of marketable securities	-21.39M
Redemptions of marketable securities
Purchases of property, plant and equipment	-3.46M
Net cash used in investing activities
Cash flows from financing activities:
Exercise of stock options	1.63M
Net cash provided by financing activities
Net decrease in cash and cash equivalents	103.56M
Cash and cash equivalents, beginning of period	54.09M
Cash and cash equivalents, end of period	157.65M

Entities mentioned with RGEN